Reference:
20220170
Release date: 13 April 2023
Release date: 13 April 2023
Promoter – Financial Intermediary
DEK VACCINES LTDLocation
Description
The project consists in a grant facility of up to EUR 5m providing seed financing to support the construction, furnishing and validation of a fill and finish vaccine manufacturing facility in the suburbs of Accra, Ghana.
Objectives
The facility will initially target vaccines that are a priority for the African continent and is expected to contribute to enhanced regional independence in health security.
Sector(s)
- Industry - Manufacturing
Proposed EIB finance (Approximate amount)
EUR 5 million
Total cost (Approximate amount)
EUR 47 million
Environmental aspects
The promoter is required to implement the project in accordance with the EIB's Environmental and Social Policy and Standards.
Procurement
The promoter is required to implement the project in accordance with the EIB's Guide to Procurement.
Status
Signed - 29/03/2023
Milestone
Under appraisal
Approved
Signed
27 March 2023
29 March 2023